NGS-based technology provides variant identification & genomic surveillance to track the emergence and prevalence of novel SARS-CoV-2 variants.
Advanced Testing in Clinical Genetics (ATCG) is proud to offer COVID-19 Sequencing based Testing, designed to reliably identify known and Novel SARS-CoV-2 variants.
ATCG’s COVID-19 Sequencing Test was developed by applying innovative Next-Generation Sequencing (NGS) technology and the cutting-edge, laboratory-developed assay that together aim to decode the genetic makeup of the all COVID-19 strains.
The outcome is a reliable test that can aid in public health surveillance strategies to understand:
ATCG has been at the forefront of responding to the COVID-19 pandemic offering state of the art rt-PCR based COVID-19 testing at an industry leading turnaround time. In addition, As Covid-19 began to evolve into new variants that were shown to be more contagious and deadly, the team at ATCG realized that it was time for testing strategies to evolve as well beyond a negative and positive test results. To do so, they have developed an innovative approach that leverages genomic data to identify current and novel covid-19 strains to offer the foresight needed to stay ahead of the pandemic. With state of facility and highly trained staff, ATCG can offer Covid-19 sequencing at scale with a short turnaround time.